BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,535.00
+95.00 (2.76%)
At close: Mar 6, 2026
-34.17%
Market Cap 17.20B
Revenue (ttm) 21.92B
Net Income (ttm) -5.63B
Shares Out 4.86M
EPS (ttm) -1,157.24
PE Ratio n/a
Forward PE n/a
Dividend 400.00 (9.96%)
Ex-Dividend Date Dec 29, 2025
Volume 13,709
Average Volume 15,659
Open 3,440.00
Previous Close 3,440.00
Day's Range 3,440.00 - 3,560.00
52-Week Range 3,200.00 - 7,620.00
Beta 0.55
RSI 27.53
Earnings Date n/a

About BioInfra

BioInfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials; immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals; and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing. It also specializes in bioequivalence testing of gener... [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.